NEWTON ROGER S 4
4 · Esperion Therapeutics, Inc. · Filed May 25, 2018
Insider Transaction Report
Form 4
NEWTON ROGER S
DirectorExecutive Chairman, CSO
Transactions
- Award
Stock Option (right tobuy)
2018-05-23+10,100→ 10,100 totalExercise: $38.32Exp: 2028-05-23→ Common Stock (10,100 underlying)
Footnotes (1)
- [F1]The options vest in full on the earlier of (i) May 23, 2019 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2018.